Pegfilgrastim Biosimilars in US Supportive Oncology: A Narrative Review of Administration Options and Economic Considerations to Maximize Patient Benefit

Granulocyte colony-stimulating factor (G-CSF) biologics, such as pegfilgrastim, are a standard of care in supportive cancer treatment that are administered once per chemotherapy cycle to reduce the incidence of febrile neutropenia. The high cost of these biologics in the United States can be a limit...

Descripción completa

Detalles Bibliográficos
Autores principales: Humphreys, Sophia Z., Geller, Robert B., Walden, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483396/
https://www.ncbi.nlm.nih.gov/pubmed/36114331
http://dx.doi.org/10.1007/s40487-022-00207-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483396/
https://www.ncbi.nlm.nih.gov/pubmed/36114331
http://dx.doi.org/10.1007/s40487-022-00207-2

Ejemplares similares